LAPTM5 Antikörper (N-Term) (FITC)
Kurzübersicht für LAPTM5 Antikörper (N-Term) (FITC) (ABIN2297076)
Target
Alle LAPTM5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 30-58, N-Term
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- LAPTM5, NT (LAPTM5, KIAA0085, Lysosomal-associated transmembrane protein 5, Lysosomal-associated multitransmembrane protein 5, Retinoic acid-inducible E3 protein) (FITC)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- LAPTM5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 30-58 amino acids from the N-terminal region of human LAPTM5.
-
Isotyp
- IgG
-
-
anti-Lysosomal Protein Transmembrane 5 (LAPTM5) (AA 23-49), (N-Term) antibody
LAPTM5 Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB27746 unconjugated
anti-Lysosomal Protein Transmembrane 5 (LAPTM5) (AA 205-262) antibodyLAPTM5 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Lysosomal Protein Transmembrane 5 (LAPTM5) antibodyLAPTM5 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Lysosomal Protein Transmembrane 5 (LAPTM5) (AA 23-49), (N-Term) antibodyLAPTM5 Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Lysosomal Protein Transmembrane 5 (LAPTM5) (AA 30-58), (N-Term) antibodyLAPTM5 Reaktivität: Human WB, FACS, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
-
